Clinical trial
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Dimebon in Patients With Mile-to-Moderate Huntington Disease
NCT00920946 is registered in ClinicalTrials.gov with Medivation, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Dimebon in Patients With Mile-to-Moderate Huntington Disease
- Lead sponsor
- Medivation, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2009
- Completion date
- Not reported
- Enrollment
- 403 (actual)
- Sites
- 37
Conditions
As the registry lists them; a condition with its own page is linked.